Page last updated: 2024-10-31

midodrine and MS (Multiple Sclerosis)

midodrine has been researched along with MS (Multiple Sclerosis) in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"Neurogenic orthostatic hypotension is often confused with other disorders of orthostatic intolerance, hypovolemic states and systemic conditions."2.50A practical guide to the treatment of neurogenic orthostatic hypotension. ( Berger, MJ; Kimpinski, K, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, MJ1
Kimpinski, K1

Reviews

1 review available for midodrine and MS (Multiple Sclerosis)

ArticleYear
A practical guide to the treatment of neurogenic orthostatic hypotension.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2014, Volume: 41, Issue:2

    Topics: Autonomic Nervous System Diseases; Central Nervous System Neoplasms; Cholinesterase Inhibitors; Dise

2014